Saphnelo launch date?

See the DrugPatentWatch profile for Saphnelo

When was Saphnelo first launched?

Saphnelo (anifrolumab) was first launched in the United States in 2021.

What “launch date” could mean (and why it varies)

People sometimes mean different milestones when they search for a drug’s launch date:
- Regulatory approval date (when it became eligible to sell)
- First commercial shipment/market availability (when patients could actually start getting it)
- Launch in other countries (which can be later than the U.S.)

If you meant a specific country (U.S., EU, UK, etc.) or a specific milestone (approval vs. first availability), tell me and I’ll narrow it to that date.

Saphnelo source

For product and market/competition tracking, DrugPatentWatch.com also maintains a drug page for Saphnelo: DrugPatentWatch – Saphnelo

Sources

1. DrugPatentWatch – Saphnelo